Henry Schein arrives at the end of a quiet week with a paradox worth examining: the borrow market looks relaxed, yet short interest has climbed roughly 35% over the past month — and an activist with a 16.4% stake sits just off-screen.
The headline tension this week is the short interest rebuild. At 7.2% of the free float, HSIC's short position is not extreme in isolation, but the pace of accumulation is striking. Shorts held just under 6.3% of the float in mid-August. By September 10, that figure had crossed above 8.9% before drifting back to the current 8.47 million shares. A one-month build of 35% deserves attention. Yet the borrow market tells a calmer story: availability runs at roughly 628% — meaning there are more than six shares available to lend for every one already borrowed — and cost to borrow has drifted down to 0.43%, off roughly 12% from a month ago. That combination says shorts are rebuilding positions at low cost into plenty of supply, which is a patient, deliberate setup rather than a squeeze-driven one.
Options positioning adds little urgency to either side. The put/call ratio at 0.35 is almost exactly in line with its 20-day average, generating a z-score barely above zero. The PCR has been notably stable across the past month, well below the 52-week high of 0.54. Options traders are not pricing in directional stress — they're sitting on their hands. Given the broader backdrop, that calm reads as indifference rather than confidence.
The most consequential fact on HSIC's register is one that rarely changes week to week but should not be buried: KKR holds a 16.4% Schedule 13D activist stake, up from 15.2% at its prior filing in March 2026. That makes KKR the largest identified holder by a wide margin, ahead of BlackRock at 6.3% and FMR LLC at around 6.1%. An activist on the 13D register with a position of this size and a demonstrated willingness to add shares is one of the most material structural facts about the stock. Stakes are as-last-disclosed around the 5% threshold; KKR's most recent filing was March 10. A separate Vanguard entity filed a 13G showing its stake had fallen to zero in March after a prior 10.2% position — a meaningful passive exit that will have changed the shareholder base dynamics materially.
The Street moved firmly in one direction after the most recent earnings print in early August. BTIG raised its target to $110 and reiterated Buy. Citigroup lifted to $112 with a Buy. Barclays moved to $100 with an Overweight. Those upgrades were followed by a second BTIG lift to $110 mid-month, after it had upgraded from Neutral to Buy in June. The mean target now runs at $98.19, representing roughly 12% upside from the current $87.43 close. The lone dissenter in recent activity is UBS, which nudged its target to $94 while holding at Neutral. BMO initiated in July at Market Perform with an $85 target, close to where the stock was then trading. The broad direction of analyst travel is constructive; the valuation is not demanding at 15x trailing earnings with EV/EBITDA near 11.8x, though neither multiple has moved sharply in either direction over the past month.
Insider activity is thin and routine. The most recent open-market purchase of note was director William Daniel buying 10,000 shares at $69.19 in May — a $692,000 bet made well below current levels. Recent September activity from the CEO of Global Distribution & Technology involved grant-related transactions, not discretionary purchases. Net insider buying is flat on a 90-day basis. The ORTEX short score has edged lower across the past two weeks, from 58.8 to 57.1, suggesting the composite short-selling signal is trending marginally less bearish even as the raw short count stays elevated.
The next scheduled earnings event falls on November 5. After August's Q2 print, the stock added 3.6% the following day and sustained a 3.1% gain over the subsequent week — a notably constructive reaction compared to a previous print where shares fell 1.6%. That earnings pattern, combined with the KKR stake and improving analyst consensus, gives the November 5 date real weight as the next inflection point for sentiment.
What to watch: whether the month-long short interest rebuild stabilises or continues to compress ahead of the November earnings date, and any new KKR Schedule 13D amendment that would update the stake level from its March disclosure.
See the live data behind this article on ORTEX.
Open HSIC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
